Below is a list of available discarded clinical and prospective cohort samples. Our samples are coded with a unique ID at time of release to the investigator. Samples are paired with a minimal amount of clinical data, further described here.
Discarded Clinical Samples
- Transport media from nasopharyngeal swabs (COVID+ and COVID- patients)
- Transport media from oropharyngeal swabs (COVID+ and COVID- patients)
- Serum (COVID+ and COVID- patients)
- Plasma (COVID+ and COVID- patients)
Prospective Cohort Samples
Inpatients
Patients admitted to BMC with COVID-19 disease. Samples are collected weekly from time of admission up until discharge
- Transport media from nasopharyngeal swabs
- Transport media from oropharyngeal swabs
- Saliva
- Peripheral blood mononuclear cell (PBMCs)
- Serum
- Plasma
- RNA stabilization tubes (i.e., BD PAXgene® tubes)
- Urine
- Stool
Ambulatory patients
Patients diagnosed with COVID-19 in the ambulatory clinic setting at BMC. Samples are collected within the first week after diagnosis, one month after diagnosis, and two months after diagnosis.
- Transport media from nasopharyngeal swabs
- Transport media from oropharyngeal swabs
- Saliva
- PBMCs
- Serum
- Plasma
- RNA stabilization tubes (i.e., BD PAXgene® tubes)
COVID-19 survivors
Individuals diagnosed with COVID-19 who are >= 2 weeks out from resolution of acute symptoms. Samples are collected 1, 2, 3, and 6, 12, 18 and 24 months after diagnosis.
- Transport media from nasopharyngeal swabs
- Transport media from oropharyngeal swabs
- Saliva
- PBMCs
- Serum
- Plasma
- RNA stabilization tubes (i.e., BD PAXgene® tubes)